Literature DB >> 20553486

Myristoylation of the dual-specificity phosphatase c-JUN N-terminal kinase (JNK) stimulatory phosphatase 1 is necessary for its activation of JNK signaling and apoptosis.

Ulla Schwertassek1, Deirdre A Buckley, Chong-Feng Xu, Andrew J Lindsay, Mary W McCaffrey, Thomas A Neubert, Nicholas K Tonks.   

Abstract

Activation of the c-JUN N-terminal kinase (JNK) pathway is implicated in a number of important physiological processes, from embryonic morphogenesis to cell survival and apoptosis. JNK stimulatory phosphatase 1 (JSP1) is a member of the dual-specificity phosphatase subfamily of protein tyrosine phosphatases. In contrast to other dual-specificity phosphatases that catalyze the inactivation of mitogen-activated protein kinases, expression of JSP1 activates JNK-mediated signaling. JSP1 and its relative DUSP15 are unique among members of the protein tyrosine phosphatase family in that they contain a potential myristoylation site at the N-terminus (MGNGMXK). In this study, we investigated whether JSP1 was myristoylated and examined the functional consequences of myristoylation. Using mass spectrometry, we showed that wild-type JSP1, but not a JSP1 mutant in which Gly2 was mutated to Ala (JSP1-G2A), was myristoylated in cells. Although JSP1 maintained intrinsic phosphatase activity in the absence of myristoylation, the subcellular localization of the enzyme was altered. Compared with the wild type, the ability of nonmyristoylated JSP1 to induce JNK activation and phosphorylation of the transcription factor c-JUN was attenuated. Upon expression of wild-type JSP1, a subpopulation of cells, with the highest levels of the phosphatase, was induced to float off the dish and undergo apoptosis. In contrast, cells expressing similar levels of JSP1-G2A remained attached, further highlighting that the myristoylation mutant was functionally compromised.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20553486      PMCID: PMC2894504          DOI: 10.1111/j.1742-4658.2010.07661.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  45 in total

1.  Regulation of STAT3-mediated signaling by LMW-DSP2.

Authors:  Y Sekine; S Tsuji; O Ikeda; N Sato; N Aoki; K Aoyama; K Sugiyama; T Matsuda
Journal:  Oncogene       Date:  2006-04-24       Impact factor: 9.867

Review 2.  Protein tyrosine phosphatases: from genes, to function, to disease.

Authors:  Nicholas K Tonks
Journal:  Nat Rev Mol Cell Biol       Date:  2006-11       Impact factor: 94.444

3.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

Authors:  A Shevchenko; M Wilm; O Vorm; M Mann
Journal:  Anal Chem       Date:  1996-03-01       Impact factor: 6.986

Review 4.  Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development.

Authors:  Y T Ip; R J Davis
Journal:  Curr Opin Cell Biol       Date:  1998-04       Impact factor: 8.382

5.  The absence of myristic acid decreases membrane binding of p60src but does not affect tyrosine protein kinase activity.

Authors:  J E Buss; M P Kamps; K Gould; B M Sefton
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

6.  MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines.

Authors:  C Tournier; C Dong; T K Turner; S N Jones; R A Flavell; R J Davis
Journal:  Genes Dev       Date:  2001-06-01       Impact factor: 11.361

7.  Rous sarcoma virus transforming protein lacking myristic acid phosphorylates known polypeptide substrates without inducing transformation.

Authors:  M P Kamps; J E Buss; B M Sefton
Journal:  Cell       Date:  1986-04-11       Impact factor: 41.582

8.  The Shp-2 tyrosine phosphatase has opposite effects in mediating the activation of extracellular signal-regulated and c-Jun NH2-terminal mitogen-activated protein kinases.

Authors:  Z Q Shi; W Lu; G S Feng
Journal:  J Biol Chem       Date:  1998-02-27       Impact factor: 5.157

Review 9.  Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases.

Authors:  D M Owens; S M Keyse
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

10.  Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer.

Authors:  Mohamed Bentires-Alj; Benjamin G Neel
Journal:  Cancer Res       Date:  2007-03-08       Impact factor: 12.701

View more
  13 in total

Review 1.  Protein tyrosine phosphatases--from housekeeping enzymes to master regulators of signal transduction.

Authors:  Nicholas K Tonks
Journal:  FEBS J       Date:  2013-01-17       Impact factor: 5.542

2.  Recurrent MSC E116K mutations in ALK-negative anaplastic large cell lymphoma.

Authors:  Rebecca A Luchtel; Michael T Zimmermann; Guangzhen Hu; Surendra Dasari; Manli Jiang; Naoki Oishi; Hailey K Jacobs; Yu Zeng; Tanya Hundal; Karen L Rech; Rhett P Ketterling; Jeong-Heon Lee; Bruce W Eckloff; Huihuang Yan; Krutika S Gaonkar; Shulan Tian; Zhenqing Ye; Marshall E Kadin; Jagmohan Sidhu; Liuyan Jiang; Jesse Voss; Brian K Link; Sergei I Syrbu; Fabio Facchetti; N Nora Bennani; Susan L Slager; Tamas Ordog; Jean-Pierre Kocher; James R Cerhan; Stephen M Ansell; Andrew L Feldman
Journal:  Blood       Date:  2019-05-17       Impact factor: 22.113

3.  Expression analyses of Dusp22 (Dual-specificity phosphatase 22) in mouse tissues.

Authors:  Nanako Hamada; Makoto Mizuno; Hiroyuki Tomita; Ikuko Iwamoto; Akira Hara; Koh-Ichi Nagata
Journal:  Med Mol Morphol       Date:  2017-12-27       Impact factor: 2.309

4.  Profiling Subcellular Protein Phosphatase Responses to Coxsackievirus B3 Infection of Cardiomyocytes.

Authors:  Millie Shah; Christian M Smolko; Sarah Kinicki; Zachary D Chapman; David L Brautigan; Kevin A Janes
Journal:  Mol Cell Proteomics       Date:  2017-02-07       Impact factor: 5.911

5.  Comparative transcriptome profiling of the human and mouse dorsal root ganglia: an RNA-seq-based resource for pain and sensory neuroscience research.

Authors:  Pradipta Ray; Andrew Torck; Lilyana Quigley; Andi Wangzhou; Matthew Neiman; Chandranshu Rao; Tiffany Lam; Ji-Young Kim; Tae Hoon Kim; Michael Q Zhang; Gregory Dussor; Theodore J Price
Journal:  Pain       Date:  2018-07       Impact factor: 7.926

6.  Scaffold Role of DUSP22 in ASK1-MKK7-JNK Signaling Pathway.

Authors:  Anna Ju; Young-Chang Cho; Ba Reum Kim; Sung Goo Park; Jeong-Hoon Kim; Kwonseop Kim; Jaehwi Lee; Byoung Chul Park; Sayeon Cho
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

Review 7.  Decoding inflammation, its causes, genomic responses, and emerging countermeasures.

Authors:  Jacek Hawiger; Jozef Zienkiewicz
Journal:  Scand J Immunol       Date:  2019-08-28       Impact factor: 3.487

8.  PI3K/Akt-independent negative regulation of JNK signaling by MKP-7 after cerebral ischemia in rat hippocampus.

Authors:  JianXi Zhu; Wei Shen; Li Gao; Hao Gu; ShuTong Shen; Yi Wang; HuiWen Wu; Jun Guo
Journal:  BMC Neurosci       Date:  2013-01-02       Impact factor: 3.288

9.  Identification of VHY/Dusp15 as a regulator of oligodendrocyte differentiation through a systematic genomics approach.

Authors:  Fanny Schmidt; Monique van den Eijnden; Rosanna Pescini Gobert; Gabriela P Saborio; Susanna Carboni; Chantal Alliod; Sandrine Pouly; Susan M Staugaitis; Ranjan Dutta; Bruce Trapp; Rob Hooft van Huijsduijnen
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

10.  RPM-1 uses both ubiquitin ligase and phosphatase-based mechanisms to regulate DLK-1 during neuronal development.

Authors:  Scott T Baker; Karla J Opperman; Erik D Tulgren; Shane M Turgeon; Willy Bienvenut; Brock Grill
Journal:  PLoS Genet       Date:  2014-05-08       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.